Cite
HARVARD Citation
Townsend, T. et al. (2020). Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn's disease. Alimentary pharmacology & therapeutics. 52 (8), pp. 1341-1352. [Online].